
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16399157
[patent_doc_number] => 20200340015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETING DISORDERS AND DISEASES USING PARTICLE DELIVERY COMPONENTS
[patent_app_type] => utility
[patent_app_number] => 16/920982
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 116384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16920982
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/920982 | DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF THE CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETING DISORDERS AND DISEASES USING PARTICLE DELIVERY COMPONENTS | Jul 5, 2020 | Pending |
Array
(
[id] => 16541295
[patent_doc_number] => 20200407708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => METHODS AND COMPOSITIONS FOR ASSESSING PROTEIN FUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/910507
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16910507
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/910507 | Methods and compositions for assessing protein function | Jun 23, 2020 | Issued |
Array
(
[id] => 16361422
[patent_doc_number] => 20200318173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/909101
[patent_app_country] => US
[patent_app_date] => 2020-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 206969
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/909101 | CRISPR enzymes and systems | Jun 22, 2020 | Issued |
Array
(
[id] => 20129433
[patent_doc_number] => 12371737
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => CRISPR enzymes and systems
[patent_app_type] => utility
[patent_app_number] => 16/909064
[patent_app_country] => US
[patent_app_date] => 2020-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 345
[patent_figures_cnt] => 388
[patent_no_of_words] => 201077
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909064
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/909064 | CRISPR enzymes and systems | Jun 22, 2020 | Issued |
Array
(
[id] => 16361372
[patent_doc_number] => 20200318123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
[patent_app_type] => utility
[patent_app_number] => 16/906580
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16906580
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/906580 | CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | Jun 18, 2020 | Pending |
Array
(
[id] => 16525506
[patent_doc_number] => 20200399586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => GENOME-WIDE RATIONALLY-DESIGNED MUTATIONS LEADING TO ENHANCED LYSINE PRODUCTION IN E. COLI
[patent_app_type] => utility
[patent_app_number] => 16/904827
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904827
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904827 | Genome-wide rationally-designed mutations leading to enhanced lysine production in | Jun 17, 2020 | Issued |
Array
(
[id] => 16650220
[patent_doc_number] => 10927385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Increased nucleic-acid guided cell editing in yeast
[patent_app_type] => utility
[patent_app_number] => 16/904405
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 42
[patent_no_of_words] => 27325
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904405
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904405 | Increased nucleic-acid guided cell editing in yeast | Jun 16, 2020 | Issued |
Array
(
[id] => 16523732
[patent_doc_number] => 20200397812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/893851
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24151
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16893851
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/893851 | INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF | Jun 4, 2020 | Abandoned |
Array
(
[id] => 17890950
[patent_doc_number] => 11453907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Crispr effector system based coronavirus diagnostics
[patent_app_type] => utility
[patent_app_number] => 16/894670
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 55
[patent_no_of_words] => 67959
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16894670
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/894670 | Crispr effector system based coronavirus diagnostics | Jun 4, 2020 | Issued |
Array
(
[id] => 16445105
[patent_doc_number] => 10837021
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-11-17
[patent_title] => Curing for recursive nucleic acid-guided cell editing
[patent_app_type] => utility
[patent_app_number] => 16/892679
[patent_app_country] => US
[patent_app_date] => 2020-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 51
[patent_no_of_words] => 36360
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 335
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16892679
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/892679 | Curing for recursive nucleic acid-guided cell editing | Jun 3, 2020 | Issued |
Array
(
[id] => 17867060
[patent_doc_number] => 20220289795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => EFFICIENT METHOD FOR PREPARING PPR PROTEIN AND USE OF THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/614231
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 989
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614231
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614231 | EFFICIENT METHOD FOR PREPARING PPR PROTEIN AND USE OF THE SAME | May 28, 2020 | Pending |
Array
(
[id] => 19504983
[patent_doc_number] => 12116394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-15
[patent_title] => Loss of function mutations in
[patent_app_type] => utility
[patent_app_number] => 16/884875
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 35692
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16884875
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/884875 | Loss of function mutations in | May 26, 2020 | Issued |
Array
(
[id] => 16296304
[patent_doc_number] => 20200282027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => SEQUENCE SPECIFIC ANTIMICROBIALS
[patent_app_type] => utility
[patent_app_number] => 16/877030
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877030
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/877030 | Sequence specific antimicrobials | May 17, 2020 | Issued |
Array
(
[id] => 16296304
[patent_doc_number] => 20200282027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => SEQUENCE SPECIFIC ANTIMICROBIALS
[patent_app_type] => utility
[patent_app_number] => 16/877030
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877030
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/877030 | Sequence specific antimicrobials | May 17, 2020 | Issued |
Array
(
[id] => 19909279
[patent_doc_number] => 12285466
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Sequence specific antimicrobials
[patent_app_type] => utility
[patent_app_number] => 16/877010
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 5942
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877010
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/877010 | Sequence specific antimicrobials | May 17, 2020 | Issued |
Array
(
[id] => 17466752
[patent_doc_number] => 11273209
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-15
[patent_title] => Methods and compositions for RNA-guided treatment of HIV infection
[patent_app_type] => utility
[patent_app_number] => 16/875271
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 48
[patent_no_of_words] => 22270
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875271
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/875271 | Methods and compositions for RNA-guided treatment of HIV infection | May 14, 2020 | Issued |
Array
(
[id] => 16686828
[patent_doc_number] => 20210069303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/874295
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874295
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/874295 | Methods and compositions for RNA-guided treatment of HIV infection | May 13, 2020 | Issued |
Array
(
[id] => 19474089
[patent_doc_number] => 12104167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Storage through iterative DNA editing
[patent_app_type] => utility
[patent_app_number] => 15/931570
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19405
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931570
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/931570 | Storage through iterative DNA editing | May 12, 2020 | Issued |
Array
(
[id] => 16506446
[patent_doc_number] => 20200385702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => RECOMBINANT TYPE I CRISPR-CAS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 15/930678
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930678
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930678 | Recombinant type I CRISPR-CAS system | May 12, 2020 | Issued |
Array
(
[id] => 16326823
[patent_doc_number] => 20200297788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => COMBINATION METHOD FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/861660
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16861660
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/861660 | COMBINATION METHOD FOR TREATMENT OF CANCER | Apr 28, 2020 | Abandoned |